How Rare Is Asthma? Prevalence, Trends, and Risk Groups

Asthma is not rare. It affects roughly 262 million people worldwide and about 25 million in the United States alone, making it one of the most common chronic diseases on the planet. Around 7.7% of the U.S. population has a current asthma diagnosis, which means roughly 1 in 13 Americans is living with the condition right now.

How Common Asthma Is by Age

In the U.S., about 8% of adults and 6.5% of children under 18 have current asthma. That translates to roughly 20.3 million adults and 4.7 million children. The condition is common enough that most schools, workplaces, and sports teams will have at least one person managing it.

A widespread assumption is that asthma is primarily a childhood disease, but the data tell a different story. About 64% of people with a physician diagnosis of asthma were first diagnosed as adults, not children. Women are especially likely to develop asthma later in life. The incidence of new diagnoses peaks in middle-aged women, and by age 38, adult-onset asthma is already the dominant form among women with the condition. For men, that crossover happens around age 50.

Who Gets Asthma Most Often

Asthma does not affect all groups equally. After adjusting for other factors, non-Hispanic Black Americans and non-Hispanic white Americans have roughly double the odds of having asthma compared to Mexican Americans, who have the lowest rates. Other Hispanic groups and other racial or ethnic groups fall in between, with odds about 1.8 to 1.9 times higher than Mexican Americans.

The reasons behind these disparities are complex. They involve differences in environmental exposures (like air pollution and housing quality), access to healthcare, socioeconomic factors, and genetic predisposition. Living in urban areas with higher pollution levels, older housing with mold or pest allergens, and limited access to preventive care all push asthma rates higher in certain communities.

Global Trends: More or Less Common Over Time

Globally, asthma has actually become less common over the past three decades, not more. The age-adjusted prevalence rate dropped by 40% between 1990 and 2021, and new diagnoses fell by about 30% over the same period. Mortality from asthma also declined during that stretch. In the U.S., asthma currently causes about 1.1 deaths per 100,000 people per year, a relatively low fatality rate for such a widespread condition.

The global decline likely reflects better air quality standards in many countries, improved treatment options, and public health interventions. However, the trend is not universal. Out of 204 countries and territories studied, the U.S. was one of just three (along with Oman and Barbados) where the age-adjusted prevalence actually increased. Researchers believe this may partly reflect better diagnostic practices and greater access to healthcare, meaning more cases are being identified rather than necessarily more people developing the disease. There was also a notable uptick in new cases globally between 2005 and 2010 before rates resumed their decline.

Most Cases Are Manageable

The vast majority of asthma cases are not severe. Among people receiving treatment, research shows roughly 16% have mild asthma (requiring only minimal medication) while about 84% fall into a moderate category needing regular inhaler therapy. Severe asthma, the kind that resists standard treatment and leads to frequent hospitalizations, represents a small fraction of total cases, generally estimated at 5 to 10% depending on the study population.

So while asthma is very common, severe or life-threatening asthma is genuinely uncommon. Most people with the condition control it well enough to live without major limitations.

Misdiagnosis Complicates the Numbers

One factor that makes asthma’s true prevalence hard to pin down is misdiagnosis. A landmark Canadian study re-evaluated 613 adults who had been told they had asthma and found that 33% of them did not actually meet the diagnostic criteria on objective testing. After a year, 30% were still off asthma medication with no problems. A similar UK study found that one-third of patients labeled as having asthma had completely normal lung function tests, and a study of patients with obesity found that 40% with a prior asthma diagnosis didn’t meet diagnostic criteria either.

This cuts both ways. Overdiagnosis means the real number of people with asthma may be somewhat lower than official figures suggest. But it also means some people are living with an incorrect label while their actual condition, sometimes something serious like heart disease or an airway obstruction, goes unrecognized. Underdiagnosis is a problem too, particularly in communities with limited healthcare access, where people may have asthma symptoms for years without ever receiving a formal diagnosis.

Putting It in Perspective

Asthma is far from rare. It ranks among the most common chronic conditions in the world, roughly on par with diabetes in terms of how many people it affects. If you or someone close to you has been diagnosed, you are in very large company. The condition is well understood, treatable in the vast majority of cases, and associated with a low mortality rate. What varies significantly is how common it is depending on your age, sex, race, and where you live.